Lineage Cell Therapeutics
LCTX
LCTX
124 hedge funds and large institutions have $182M invested in Lineage Cell Therapeutics in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 27 increasing their positions, 39 reducing their positions, and 16 closing their positions.
Holders
124
Holders Change
+9
Holders Change %
+7.83%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
27
Reduced
39
Closed
16
Calls
$1.61M
Puts
$289K
Net Calls
+$1.32M
Net Calls Change
+$448K
Top Buyers
1 |
1
BlackRock
New York
|
$24.5M |
2 |
2
Allspring Global Investments
Charlotte,
North Carolina
|
$1.28M |
3 |
RA
3
Raffles Associates
New York
|
$1.33M |
4 |
4
Morgan Stanley
New York
|
$1.3M |
5 |
5
Millennium Management
New York
|
$816K |